Godesburg’s Haven Investment Letter is a daily email that dissects – and puts into perspective – the key events in today’s financial world. Authors Garrett Baldwin and Dr. Gregor Bauer give insights into the major fundamental and technical indicators driving the markets, giving readers an inside edge on major opportunities misunderstood or undiscovered by Wall Street analysts and media insiders.
Yesterday I presented to you some of the top dividend aristocrats from the S&P 500 Index. Today I will show you 3 more candidates that
Today, I want to discuss two biotech companies that look promising for the rest of the year. First, Pfizer (NYSE:PFE). The company was established in
Momentum is Red. Markets continued to break down on Thursday after the Federal Reserve announced plans to raise interest rates to 3% and told investors
Momentum is Red. The central bank will raise interest rates by at least 75 basis points during its September meeting. Federal Reserve Chairman Jerome Powell
Momentum is Red. With that said, I’ve moved to cash and taken a speculative long position on the SPY into Wednesday and stopped shorting the